GLP-1RAs affect different types of liver disease
Poor sleep increases cortisol, drives insulin resistance, increases hunger hormones (even partially overriding GLP-1 appetite suppression), and impairs recovery from exercise
New England of Journal Medicine , 2021;384(11):989-1002
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company
Molecular Structures of FDA Approved Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Description This figure template "Molecular Structures of FDA Approved Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA)" is assembled using dynamic BioRender assets (icons, lines, shapes and/or text) and is fully editable
However, the effects can vary from person to person, with some individuals noticing a reduction in hunger sooner than others